Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Gastrointestinal cancer Definition Gastrointestinal cancer (GI) occurs when there are uncontrolled, abnormal cells growing in the gastrointestinal tract. GI cancers can appear anywhere along the long twisting tube that includes the esophagus, stomach, small and large intestine (which includes the colon), rectum and anus (Discovermi.org - SNM, 2011). Role of molecular imaging Molecular imaging has become an essential tool in the diagnosis, evaluation and treatment of patients with gastrointestinal cancers. Positron emission tomography (PET) and PET combined with computed tomography (PET/CT) are used to diagnose the disease and monitor treatment. PET/CT imaging is used in various forms of GI cancers: Gastric cancer (Discovermi.org - SNM, 2011) o To determine response to therapy Small bowel tumors (Discovermi.org - SNM, 2011) o To diagnose and monitor the treatment Esophageal, pancreatic and gastric (stomach) cancers o To pinpoint the location of the spread of cancer GI lymphoma (Discovermi.org - SNM, 2011) o To establish size, level of progression and stage o To monitor response to treatment for Hodgkin’s and non-Hodgkin's lymphoma o To distinguish whether there has been a recurrence Colorectal cancer o Assess level of disease progression and whether metastasis is present (SNM, 2009) o Helps monitor effectiveness of treatment (SNM, 2009) o Distinguish whether there has been a recurrence at completion of treatment (SNM, 2009) o Provides valuable information for physicians to make better informed decisions on patient management (SNM, 2009) Radiopharmaceutical Manufacturer Fluorine-18 fluorodeoxyglucose Various Indium-111 pentetreotide Covidien Trade names Approved indications in adults (pediatric use as noted) As a PET imaging agent to: Assess abnormal glucose metabolism TM Octreoscan An agent for the scintigraphic localization of primary and metastatic neuroendocrine tumors bearing somatostatin receptors MSDS and package insert information © 2015 Cardinal Health. All rights reserved. CARDINAL HEALTH, the Cardinal Health LOGO and ESSENTIAL TO CARE are trademarks or registered trademarks of Cardinal Health. All other marks are the property of their respective owners. .